Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme Harrogate, Leeds and York – Public Health England

Executive summary of quality assurance (QA) visit in Harrogate, Leeds and York held on 18 and 19 March 2019.  

Screening Quality Assurance visit report: NHS Cervical Screening Programme Homerton University Hospital NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Homerton Hospital NHS Foundation Trust held on 1 February 2019.

Screening Quality Assurance visit report: NHS Breast Screening Programme Doncaster Hospitals NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Doncaster Hospitals NHS Foundation Trust held on 5 March 2019.  

Screening Quality Assurance visit report: NHS Cervical Screening Programme Northern Lincolnshire and Goole NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Northern Lincolnshire and Goole NHS Foundation Trust held on 19 and 20 March 2019.

HSC (2008) 001 Updated national guidance on the safe administration of intrathecal chemotherapy – Department of Health

This circular covers the updated National Guidance on the Safe Administration of Intrathecal Chemotherapy. This updated guidance replaces HSC 2003/010. It sets out the minimum that should be expected of an NHS Trust providing an intrathecal chemotherapy service. It also

HSC (2000) 021: Improving the quality of cancer services – Department of Health

Improving the quality of our cancer services is a priority in the National Priorities Guidance for 2000/01 to 2002/3. This Circular announces consultation on a manual of national standards and performance indicators to provide the framework for assessment of the

Proton Beam Therapy for Oesophageal Cancer: Engagement Report for Clinical Commissioning Policies – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat oesophageal cancer with proton beam therapy (PBT) in adults and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Proton Beam Therapy for Oesophageal Cancer: Clinical Priorities Advisory Group – NHS England and NHS Improvement

This policy statement recommends that proton beam therapy (PBT), a form of radiotherapy, should not be made routinely available for the treatment of oesophageal cancer in adults. This treatment is not currently available in this indication and therefore does not

Patient insights on cancer care: opportunities for improving efficiency: Findings from the international All.Can patient survey – All.Can

All.Can report detailing the responses of almost 4,000 cancer patients and caregivers from more than ten countries who responded to a survey to share their experiences of cancer care. While most reported that their needs were sufficiently addressed during their

Rapid Diagnostic Centres: Vision and 2019/20 Implementation Specification – NHS England

This document outlines the vision and approach for how Rapid Diagnostic Centres will develop and support the transformation of cancer diagnosis services over time. It also provides an implementation specification for Cancer Alliances to begin setting up Rapid Diagnostic Centres

Proton Beam Therapy for Oesophageal Cancer: Engagement Report for Clinical Commissioning Policies – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat oesophageal cancer with proton beam therapy (PBT) in adults and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Proton Beam Therapy for Oesophageal Cancer: Policy Statement – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat oesophageal cancer with proton beam therapy (PBT) in adults and have concluded that there is not enough evidence to make the treatment available through routine commissioning.